Product Description

Alfuzosin Hydrochloride IP 10 mg + Dutasteride 0.5 mg is a combination pharmaceutical formulation developed for the effective management of benign prostatic hyperplasia (BPH) under medical supervision. The formulation combines two complementary active ingredients that work together to help relieve urinary symptoms associated with an enlarged prostate gland while supporting long-term prostate health management.

Benign prostatic hyperplasia is a common condition in aging men that can cause symptoms such as difficulty in urination, weak urine flow, frequent urination, nighttime urination, incomplete bladder emptying, and urinary discomfort. This combination therapy is designed to provide both symptomatic relief and long-term reduction in prostate enlargement, improving overall urinary function and patient comfort.

Alfuzosin Hydrochloride belongs to the alpha-blocker class of medicines and works by relaxing the muscles in the prostate and bladder neck. This action helps improve urine flow, reduce urinary obstruction, and relieve discomfort associated with urinary difficulties.

Dutasteride works by inhibiting the conversion of testosterone into dihydrotestosterone (DHT), a hormone responsible for prostate enlargement. By reducing DHT levels, Dutasteride helps decrease prostate size over time and supports long-term management of BPH symptoms.

The combination of Alfuzosin Hydrochloride and Dutasteride offers a dual-action approach by providing rapid symptomatic relief while also addressing the underlying cause of prostate enlargement. This comprehensive mechanism helps improve urinary flow, reduce urinary retention risk, and support better quality of life during long-term treatment.

Manufactured under stringent WHO-GMP quality standards, the formulation is produced using advanced pharmaceutical technologies and undergoes comprehensive quality testing to ensure safety, efficacy, purity, and pharmaceutical consistency. Every batch is carefully monitored to maintain dependable therapeutic performance and high-quality healthcare standards.

Key Features

• Dual-action formulation for BPH management
• Helps improve urinary flow and bladder function
• Supports long-term prostate health management
• Helps reduce symptoms of enlarged prostate
• Reliable and consistent therapeutic performance
• Manufactured under strict WHO-GMP standards
• Produced using advanced pharmaceutical processes

Uses

• Benign prostatic hyperplasia (BPH) management
• Urinary flow improvement support
• Relief from enlarged prostate symptoms
• Long-term prostate health support under medical supervision

How It Works

Alfuzosin Hydrochloride relaxes muscles in the prostate and bladder neck to improve urine flow, while Dutasteride reduces DHT levels to help decrease prostate enlargement over time.

Possible Side Effects

Common side effects may include:

• Dizziness
• Headache
• Fatigue
• Reduced libido
• Ejaculation disorders
• Nasal congestion
• Low blood pressure

Patients should seek medical attention if severe allergic reactions, chest pain, fainting, or unusual symptoms occur.

Precautions

• Use only under medical supervision
• Inform your doctor about liver conditions or blood pressure disorders
• Avoid overdose or self-medication
• Use cautiously in elderly patients
• Pregnant women should avoid handling damaged tablets or capsules containing Dutasteride

Storage Instructions

Store in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children and use before the expiry date mentioned on the packaging.

Quality Assurance

Manufactured in WHO-GMP certified facilities, the formulation undergoes stringent quality control procedures and comprehensive testing to ensure safety, efficacy, purity, and dependable therapeutic performance.